# FDA Inspection 1208559 - Piramal Pharma Limited - May 19, 2023

Source: https://www.keypedia.com/records/fda_inspections/piramal-pharma-limited/a4ba4e7e-941f-41fa-a7cb-68c2a95d2ced
Source feed: FDA_Inspections

> FDA Inspection 1208559 for Piramal Pharma Limited on May 19, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1208559
- Company Name: Piramal Pharma Limited
- Inspection Date: 2023-05-19
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1103288 - 2019-08-30](https://www.keypedia.com/records/fda_inspections/piramal-pharma-limited/86b06f35-28c9-4f71-bae0-6fefd203f2c6)
- [FDA Inspection 1081925 - 2019-01-18](https://www.keypedia.com/records/fda_inspections/piramal-pharma-limited/bc0d5890-f35f-4e9e-b3f6-0522a2adead4)
- [FDA Inspection 1005197 - 2017-02-21](https://www.keypedia.com/records/fda_inspections/piramal-pharma-limited/4d5108d6-21cc-4fe9-b32e-d5c82096ac34)
- [FDA Inspection 951067 - 2015-10-30](https://www.keypedia.com/records/fda_inspections/piramal-pharma-limited/cab5b902-5063-479b-9d40-21eeff2bce2a)
- [FDA Inspection 951067 - 2015-10-30](https://www.keypedia.com/records/fda_inspections/piramal-pharma-limited/46a46e31-1964-4dd5-975c-4e50d7260d0c)

Company: https://www.keypedia.com/companies/piramal-pharma-limited/b492136d-42a5-47e3-a443-53373398d2c9

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c